KIF20A and breast carcinoma: Using BM-DC-based peptide immunization, we sought to identify the Th-cell epitope in KIF20A, which is frequently overexpressed in gastric cancer [25], melanoma [26], lung cancer, pancreatic cancer [27], bladder cancer, breast cancer, and various other malignancies [28], and thus is a promising target for cancer immunotherapy [29].